KPA Requests Post-Marketing Surveillance on Roche Korea's Caldivita

The Korea Pharmaceutical Association (KPA) announced on March 21st that it has submitted a request to the Korea Food and Drug Association (KFDA) for an undertaking of post-marketing surveillance on the alleged substandard product qualities of Roche Korea's Caldivita.

The request is based on the allegations reported to the KPA that the retail pharmacies have discovered the broken tablets of C...